|Year : 2020 | Volume
| Issue : 5 | Page : 2514-2516
Kounis syndrome: A rare case
Ashok Sunder, Bijaya Mohanty, Abha Singh
Department of Medicine, Tata Main Hospital, Jamshedpur, Jharkhand, India
|Date of Submission||07-Mar-2020|
|Date of Decision||28-Mar-2020|
|Date of Acceptance||15-Apr-2020|
|Date of Web Publication||31-May-2020|
Dr. Bijaya Mohanty
Department of Medicine, Tata Main Hospital, Jamshedpur, Jharkhand; Postal Address: AC11 K, L, 11th Phase, Adarsh Nagar, Sonari, Jamshedpur - 831 011, Jharkhand
Source of Support: None, Conflict of Interest: None
Allergic angina and allergic myocardial infarction are ubiquitous diseases covering a wide spectrum of mast cell activation disorders, which are associated with acute coronary syndromes and are referred to as ''Kounis Syndrome''. Here, we report a case admitted with dyspnea and mild chest heaviness secondary to bee sting, later diagnosed as Kounis syndrome.
Keywords: Allergic myocardial infarction, Kounis syndrome, vasospastic
|How to cite this article:|
Sunder A, Mohanty B, Singh A. Kounis syndrome: A rare case. J Family Med Prim Care 2020;9:2514-6
| Introduction|| |
The acute coronary syndrome resulting from an allergic reaction is referred to as Kounis syndrome. Kounis and Zafras reported the first case in 1991. American Heart Journal in 1950 published the first case of allergic angina due to prolonged use of penicillin. The aim of presenting this case is to highlight this rare syndrome. Brown et al. reported that 9.5% of healthy volunteers developed chest pain after an insect sting challenge. All of them had electrocardiographic abnormalities consistent with acute myocardial ischemia. Here, we present a case of Kounis syndrome caused by bee sting injury.
| Case Summary|| |
A 59-year-old male was admitted with complaints of breathlessness and chest pain along with radiation to the left arm after bee sting injury. He is a diabetic and was on insulin therapy for the last 10 years. There was no past history of allergy or asthma and he had no kind of addictions. Approval obtained (15/01/2020).
On admission, the patient was dyspneic with a respiratory rate of 24/min, with tachycardia (pulse rate 100/min), raised jugular venous pulse (JVP) and blood pressure of 140/96 mm/Hg. Chest examination revealed the presence of bilateral basal crepitations with normal first and second heart sounds besides an S3 gallop. Other systemic examinations were non-contributory.
Blood investigations showed an increase in cardiac biomarkers CKMB -346.2, LDH -766.2, and CPK-2806.5 with slight increase in Trop-I level-0.03 ng/ml, serum cholesterol-250 mg/dl, low-density lipoprotein (LDL)-140 mg/dL, and high-density lipoprotein (HDL)-62 mg/dL. Echocardiogram (ECG) demonstrated ST elevation from V1–V5 suggestive of an anterior infarct [Figure 1] and [Figure 2] while the chest X-ray showed pulmonary edema [Figure 3]. The echocardiographic finding revealed an ejection fraction of 50%, grade 1 diastolic dysfunction along with regional wall motion abnormality (RWMA) in the mid anterior septum, distal interventricular septum (IVS), apex and distal anterior wall and an atherosclerotic aortic valve. Myocardial perfusion scan (single-photon emission computed tomography (SPECT)) revealed a reversible anterior and apical wall perfusion defect involving 23% of total myocardium with resting left ventricular (LV) ejection fraction within normal limits. Exercise had to be terminated as the patient developed chest pain during the procedure.
|Figure 1: ECG showing ST elevation in V1-V5 suggestive of anterior infarct|
Click here to view
Treatment of Kounis syndrome consists of aborting the allergic reaction followed by the stabilization of coronary vasculature with medical/interventional techniques. Accordingly, our patient was treated with corticosteroids (Inj methyl prednisolone), low molecular weight heparin (Inj loparin), antiplatelets (ecosprin and clopidogrel), tab atorvastatin and was discharged home safely to be followed up at a higher center.
A coronary angiography done at the higher center revealed a triple vessel disease with 90% lesion in left anterior descending (LAD), 80-85% lesion in OM1, 90% in OM2, and 40% in right coronary (RCA) [Figure 4] following which an interventional technique (coronary artery bypass graft (CABG)) was performed.
|Figure 4: Coronary angiography revealed LAD: 90% lesion in proximal third, another 70% lesion, in the middle third, diffusely diseased distally)|
Click here to view
| Discussion|| |
Clinical, laboratory, and electrocardiographic findings of classic angina pectoris can be caused by various inflammatory mediators, e.g. histamines, neutral proteases, arachidonic acid products, platelet-activating factor and a variety of cytokines and chemokines released during the allergic insult., The underlying pathophysiology in Kounis syndrome is due to coronary vasospasm and atheromatous plaque rupture. Braunwald noted that allergic reactions can lead to vasospastic angina. The mediators like histamine and leukotrienes are the main culprits causing vasospasm of coronary vascular smooth muscle. Even the mediators like tryptase are also documented in the pathogenetic mechanism of allergic angina and infarction. This activates interstitial collagenase, gelatinase, and stromelysin, which erode the atheromatous plaques resulting in rupture of plaque and thrombus formation.
Kounis syndrome is divided into three subtypes:
Type I patients don't have any predisposing factors for coronary artery disease. The allergic event leads to coronary artery spasm resulting in chest pain and ECG changes. Cardiac enzymes level may be normal., These cases have a normal myocardial perfusion scan, normal coronary angiogram, and positive ergonovine test. The explanation for this type would be endothelial dysfunction or microvascular angina.
In Type II, there is angiographic evidence of coronary artery disease during an acute allergic reaction., This type includes patients with pre-existing atheromatous disease and an acute allergic episode induces plaque erosion or rupture manifesting as an acute myocardial infarction.,,
In Type III patients with coronary thrombosis (including stent thrombosis), the presence of eosinophils and mast cells have been demonstrated. Our case fits into KS type II, diagnosis based on history and clinical evaluation. The patient was referred to a higher cardiac center after discharge where an angiography performed showed multiple vessels coronary artery disease with normal LV systolic function and the patient was advised to go in for CABG, which ultimately restored him to normal.
The clinical presentation of Kounis syndrome includes a mixture of symptoms and signs of an allergic reaction and acute coronary syndrome with chest pain, faintness, dyspnea, nausea, vomiting, syncope, urticaria, pruritus, diaphoresis, palpitations, pallor, hypotension, bradycardia, etc. Multiple agents may result in this syndrome. Honeybee stings contain peptides, proteins, and vasoactive amines, including histamine, acetylcholine, norepinephrine, dopamine, and 5-hydroxytryptamine, which are responsible for angina which happened in our case.
Forman et al. describe a case of severe allergic vasospastic angina and sudden death, where the autopsy showed mast cell infiltration at the site of coronary artery spasm. Mast cells are abundant in the heart, myocardial fibers, around coronary arteries, within arterial intima and intramural vessels, and atherosclerotic plaques. During anaphylaxis, they are responsible for the acute coronary syndrome. Even recently one young woman presented with acute coronary syndrome secondary to allergic vasospasm.
Allergic reactions can occur secondary to various chemicals, food materials, and insect bites. Patients may present with various symptoms ranging from trivial to life-threatening situations like Kounis syndrome. Therefore, it is essential for family physicians to identify and treat these cases early.
| Conclusions|| |
Myocardial infarction is a rare complication of anaphylactic reactions due to bee sting. Thorough clinical examination and investigations including ECG and ECHO are recommended in all patients developing hypersensitivity reactions for prompt diagnosis and treatment. In case a previously normal patient develops acute coronary spasm, all possible causes of allergy should be looked for.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kounis NG, Zavras GM. Histamine-induced coronary artery spasm: The concept of allergic angina. Br J Clin Pract 1991;45:121-8.
Pfister CW, Plice SG. Acute myocardial infarction during a prolonged allergic reaction to penicillin. Am Heart J 1950;40:945-7.
Brown SG, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 2004;21:149-54.
Kounis NG, Zavras GM. Allergic angina and allergic myocardial infarction. Circulation 1996;94:1789.
Kounis NG, Grapsas GM, Goudevenos JA. Unstable angina, allergic angina and allergic myocardial infarction. Circulation 1999;100:el 56.
Brawnvald E. Unstable angina. An etiologic approach to management. Circulation 1998;98:2219-22.
Kounis NG. Serum tryptase levels and Kounis syndrome. Int J Cardiol 2007;114:407-8.
Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): A natural paradigm? Int J Cardiology 2006;110:7-14.
Kounis GN, Soufras GD, Kouni SA, Kounis NG. Hypersensitivity myocarditis and hypersensitivity coronary syndrome (Kounis syndrome). Am J Emerg Med 2009;27:506-8.
Tavil Y, Turfan M, Türkoǧlu S, Abaci A. Kounis syndrome secondary to amoxicillin/clavulanic acid use. Int J Cardiol 2008;124:e4-7.
Vivas D, Rubira JC, Ortiz AF, Macaya C. Coronary spasm and hypersensitivity to amoxicillin: Kounis or not Kounis syndrome? Int J Cardiol 2008;128:279-81.
González-de-Olano D, Alvarez-Twose I, Matito A, Sánchez-Muñoz L, Kounis NG, Escribano L. Mast cell activation disorders presenting with cerebral vasospasm-related symptoms: A “Kounis-like” syndrome? Int J Cardiol 2011;150:210-1.
Kogias JS, Sideris SK, Anifadis SK. Kounis syndrome associated with hypersensitivity to hymenoptera stings. Int J Cardiol 2007;114:252-5.
Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ 2nd
, Virmani R. Increased adventitial mast cells in a patient with coronary spasm. N
Engl J Med 1985;313:1138-41.
Forlani D, Scarano G, D'Alleva A, Di Marco M, Paloscia L, Gatta A, et al
. Kounis syndrome as first manifestation of allergic sensitization. Case Reports in Medicine 2019.
Rashedi N, Bennett C. Young woman presenting with acute coronary syndrome secondary to allergic coronary vasospasm (Kounis Syndrome). J Am Coll Cardiol 2020;75(Suppl 1):1-3.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]